This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 Jun;30(6):1127-9.

Tumor necrosis factor inhibitors "SPARCC" an interest in consensus

Allen Sawitzke, Daniel O Clegg

PMID: 12784378

Review

Tumor necrosis factor inhibitors "SPARCC" an interest in consensus

Allen Sawitzke et al. J Rheumatol. 2003 Jun.

. 2003 Jun;30(6):1127-9.

Authors

Allen Sawitzke, Daniel O Clegg

PMID: 12784378

No abstract available

PubMed Disclaimer

Comment on

Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis.
Maksymowych WP, Inman RD, Gladman D, Thomson G, Stone M, Karsh J, Russell AS; Spondyloarthritis Research Consortium of Canada (SPARCC). Maksymowych WP, et al. J Rheumatol. 2003 Jun;30(6):1356-63. J Rheumatol. 2003. PMID: 12784417 Review.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Tumor necrosis factor inhibitors "SPARCC" an interest in consensus

Tumor necrosis factor inhibitors "SPARCC" an interest in consensus

Authors

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources